
16.22 Delayed Data As of May 26 | ![]() Today’s Change | 15.16 Today|||52-Week Range 28.06 | -30.51% Year-to-Date |
The 18 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 37.00 and a low estimate of 20.00. The median estimate represents a +91.12% increase from the last price of 16.22.
The current consensus among 21 polled investment analysts is to Hold stock in ACADIA Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.